Follicular bronchitis in the pediatric population

B T Kinane1, A L Mansell, R G Zwerdling

  • 1Pediatric Pulmonary Unit, Massachusetts General Hospital, Boston.

Chest
|October 1, 1993
PubMed

Insights

Idiopathic follicular bronchitis (IFB) in children presents with chronic cough and tachypnea. Most patients improve by age four, though some experience residual obstructive lung disease.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Rare Pediatric Diseases

Background:

  • Idiopathic follicular bronchitis (IFB) is a rare pediatric respiratory condition.
  • Diagnosis typically requires invasive procedures like open lung biopsy.
  • Understanding IFB's natural history and clinical course is crucial for management.

Observation:

  • Five pediatric patients diagnosed with IFB via open lung biopsy were retrospectively studied.
  • Clinical presentation included tachypnea and chronic cough from early infancy.
  • Physical exam revealed diffuse crackles or rhonchi, and chest X-rays showed interstitial patterns.

Findings:

  • No autoimmune or collagen vascular diseases were identified.
  • Corticosteroid therapy showed minimal efficacy.
  • No viral or bacterial pathogens were isolated from respiratory samples.
  • All patients demonstrated improvement between 2-4 years of age.
  • Older patients exhibited mild residual obstructive lung disease.

Implications:

  • This case series provides initial insights into IFB in a pediatric cohort.
  • The findings suggest IFB may have a self-limiting course in children.
  • Further research is needed to elucidate the pathogenesis and optimal treatment strategies for IFB.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...